An established hallmark of mesothelioma lies in its chronic inflammatory nature, and given the intricate relationship between specific metabolic states, notably heightened mitochondrial activity coupled with ROS production, and the NF-κB pathway, we embarked on an investigation into the dysregulation of NF-κB activity in mesothelioma. The gene discussed is NFKB1; the disease is mesothelioma.